Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSorbic acid is an activator of hFFA2-DREADDs. Inhibits forskolin-induced cAMP production (IC50 ∼ 1 μM) and promotes accumulation of inositol monophosphates (IC50 >1 μM) in cells expressing hFFA2-DREADD. Promotes the release of GLP-1 from colonic crypts derived from hFFA2-DREADD-expressing mice.
分子量 | 112.13 |
公式 | C6H8O2 |
储存 | Store at +4°C |
纯度 | ≥98% (HPLC) |
CAS Number | 110-44-1 |
PubChem ID | 643460 |
InChI Key | WSWCOQWTEOXDQX-MQQKCMAXSA-N |
Smiles | CC=CC=CC(=O)O |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Bolognini et al (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nat.Chem.Biol. 15 489 PMID: 30992568
关键词: Sorbic acid, Sorbic acid supplier, free, fatty, acid, receptor, DREADD, agonists, agonism, designer, receptors, activated, by, drugs, chemogenetics, DREADDs, ligands, Free, Fatty, Acid, Receptors, 7119, Tocris Bioscience
目前没有该产品的评论。 Be the first to review Sorbic acid and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
Produced by Tocris, the chemogenetics research bulletin provides an introduction to chemogenetic methods to manipulate neuronal activity. It outlines the development of RASSLs, DREADDs and PSAMs, and the use of chemogenetic compounds. DREADD ligands and PSEMs available from Tocris are highlighted.
GPCRs can interact with multiple distinct transducers or regulatory proteins and these can be preferentially engaged in an agonist-specific manner giving rise to biased agonism. This poster discusses cutting edge GPCR signaling pharmacology and highlights therapeutic applications of biased agonism.